Arndt Vogel on the NALIRICC trial of nanoliposomal irinotecan in pretreated advanced biliary tract cancer The Lancet Gastroenterology & Hepatology in conversation with

https://www.thelancet.com/multimedia/podcasts/in-conversation-with/langas?utm_campaign=update-langas&utm_medium=email&_hsenc=p2ANqtz-97g1TcnOuJRixEB2LXcURx3h_CWIIYCdHEh24U27vtMaXWjGFP1LiMkGYWpCEWZVo7T720EgNaYDDaGZFphQKq5NstPQ&_hsmi=330294053&utm_content=330273338&utm_source=hs_email